01/10/2023
The Health Canada eSTAR pilot program
The FDA and Health Canada are conducting a joint pilot. The pilot will test the use of a single eSTAR submitted to both the FDA and Health Canada. The feasibility of using eSTAR will be determined by the outcome of a pilot with 9 participants. Selected participants will use the non-In Vitro Diagnostic eSTAR, which follows the structure of the IMDRF Non-In Vitro Diagnostic Device Market Authorization Table of Contents (nIVD MA ToC).
11/15/2022
Guidance on clinical evidence requirements for medical devices: Overview
"This document provides guidance to manufacturers of Class II, III and IV medical devices and regulatory representatives on the clinical evidence requirements for medical devices. Guidance is provided on:
when clinical data/evidence is required
the common methods to generate clinical data
how to compare devices appropriately"
01/07/2022
Consultation for proposed amendments to the Medical Device Regulations
"The proposed amendments for medical devices would: Streamline MDEL application requirements to reflect current practices.
Provide the Minister with new and expanded authorities over MDELs, including the ability to issue terms and conditions on an MDEL and partially suspend or cancel an MDEL to mitigate risks to health and safety.
Implement ministerial authority to order recalls of medical devices, harmonize the definition of a recall and clarify industry reporting obligations in guidance."
How can RegDesk help?
RegDesk is an AI-powered Regulatory Information Management System (RIMS) designed to simplify global compliance for medical device companies. With regulatory intelligence covering 120+ markets, RegDesk helps you prepare and publish global submissions, manage standards, conduct impact assessments, and stay ahead of regulatory changes all from a single, centralized platform. Expanding into new markets has never been easier.